Case of relapsed CD20(+) mixed‐cellularity Hodgkin disease treated with sequential rituximab and radiotherapy
Gespeichert in:
| Veröffentlicht in: | American journal of hematology 2004-12, Vol.77 (4), p.418-419 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 419 |
|---|---|
| container_issue | 4 |
| container_start_page | 418 |
| container_title | American journal of hematology |
| container_volume | 77 |
| creator | Karamouzis, Michalis V. Apostolikas, Nikiforos Georganta, Chara Lainakis, Giorgos Kandylis, Kostas Rigatos, Gerasimos |
| description | |
| doi_str_mv | 10.1002/ajh.20224 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19730656</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19730656</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3564-7cc9790201768d2adc113a800a382fab2166d5cb8042ab9695bc6d700cb54a9e3</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EouWx4AeQVwiECmMnduJlVR4FIbGBdTSxXeqSNsVO1HbHJ_CNfAkurcSK1czi3KOZS8gJgysGwK9xMr7iwHm6Q7oMlOzlUvBd0oVEsriD6pCDECYAjKU57JMOE0IwrliX1AMMltYj6m2F82ANHdxwOL-8oFO3tOb780vbqmor9K5Z0WFt3t7djBoX7DrXeItNzCxcM6bBfrR21jisaITbpZtiSXFmqEfj6mZsPc5XR2RvhFWwx9t5SF7vbl8Gw97T8_3DoP_U04mQaS_TWmUKOLBM5oaj0YwlmANgkvMRlpxJaYQuc0g5lkoqUWppMgBdihSVTQ7J2cY793U8KzTF1IX1KzizdRsKprIEpJARvNiA2tcheDsq5j5e7lcFg2LdbhHbLX7bjezpVtqWU2v-yG2dEbjeAAtX2dX_pqL_ONwofwB7Y4TI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19730656</pqid></control><display><type>article</type><title>Case of relapsed CD20(+) mixed‐cellularity Hodgkin disease treated with sequential rituximab and radiotherapy</title><source>MEDLINE</source><source>Wiley Online Library</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Karamouzis, Michalis V. ; Apostolikas, Nikiforos ; Georganta, Chara ; Lainakis, Giorgos ; Kandylis, Kostas ; Rigatos, Gerasimos</creator><creatorcontrib>Karamouzis, Michalis V. ; Apostolikas, Nikiforos ; Georganta, Chara ; Lainakis, Giorgos ; Kandylis, Kostas ; Rigatos, Gerasimos</creatorcontrib><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.20224</identifier><identifier>PMID: 15551291</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Aged ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Murine-Derived ; Antigens, CD20 - immunology ; Antineoplastic Agents - therapeutic use ; Combined Modality Therapy ; Hodgkin Disease - drug therapy ; Hodgkin Disease - immunology ; Hodgkin Disease - pathology ; Hodgkin Disease - radiotherapy ; Humans ; Male ; Recurrence ; Reed-Sternberg Cells - immunology ; Rituximab ; Treatment Outcome</subject><ispartof>American journal of hematology, 2004-12, Vol.77 (4), p.418-419</ispartof><rights>Copyright © 2004 Wiley‐Liss, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3564-7cc9790201768d2adc113a800a382fab2166d5cb8042ab9695bc6d700cb54a9e3</citedby><cites>FETCH-LOGICAL-c3564-7cc9790201768d2adc113a800a382fab2166d5cb8042ab9695bc6d700cb54a9e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.20224$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.20224$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15551291$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karamouzis, Michalis V.</creatorcontrib><creatorcontrib>Apostolikas, Nikiforos</creatorcontrib><creatorcontrib>Georganta, Chara</creatorcontrib><creatorcontrib>Lainakis, Giorgos</creatorcontrib><creatorcontrib>Kandylis, Kostas</creatorcontrib><creatorcontrib>Rigatos, Gerasimos</creatorcontrib><title>Case of relapsed CD20(+) mixed‐cellularity Hodgkin disease treated with sequential rituximab and radiotherapy</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><subject>Aged</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Murine-Derived</subject><subject>Antigens, CD20 - immunology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Hodgkin Disease - drug therapy</subject><subject>Hodgkin Disease - immunology</subject><subject>Hodgkin Disease - pathology</subject><subject>Hodgkin Disease - radiotherapy</subject><subject>Humans</subject><subject>Male</subject><subject>Recurrence</subject><subject>Reed-Sternberg Cells - immunology</subject><subject>Rituximab</subject><subject>Treatment Outcome</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOwzAQRS0EouWx4AeQVwiECmMnduJlVR4FIbGBdTSxXeqSNsVO1HbHJ_CNfAkurcSK1czi3KOZS8gJgysGwK9xMr7iwHm6Q7oMlOzlUvBd0oVEsriD6pCDECYAjKU57JMOE0IwrliX1AMMltYj6m2F82ANHdxwOL-8oFO3tOb780vbqmor9K5Z0WFt3t7djBoX7DrXeItNzCxcM6bBfrR21jisaITbpZtiSXFmqEfj6mZsPc5XR2RvhFWwx9t5SF7vbl8Gw97T8_3DoP_U04mQaS_TWmUKOLBM5oaj0YwlmANgkvMRlpxJaYQuc0g5lkoqUWppMgBdihSVTQ7J2cY793U8KzTF1IX1KzizdRsKprIEpJARvNiA2tcheDsq5j5e7lcFg2LdbhHbLX7bjezpVtqWU2v-yG2dEbjeAAtX2dX_pqL_ONwofwB7Y4TI</recordid><startdate>200412</startdate><enddate>200412</enddate><creator>Karamouzis, Michalis V.</creator><creator>Apostolikas, Nikiforos</creator><creator>Georganta, Chara</creator><creator>Lainakis, Giorgos</creator><creator>Kandylis, Kostas</creator><creator>Rigatos, Gerasimos</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>200412</creationdate><title>Case of relapsed CD20(+) mixed‐cellularity Hodgkin disease treated with sequential rituximab and radiotherapy</title><author>Karamouzis, Michalis V. ; Apostolikas, Nikiforos ; Georganta, Chara ; Lainakis, Giorgos ; Kandylis, Kostas ; Rigatos, Gerasimos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3564-7cc9790201768d2adc113a800a382fab2166d5cb8042ab9695bc6d700cb54a9e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Murine-Derived</topic><topic>Antigens, CD20 - immunology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Hodgkin Disease - drug therapy</topic><topic>Hodgkin Disease - immunology</topic><topic>Hodgkin Disease - pathology</topic><topic>Hodgkin Disease - radiotherapy</topic><topic>Humans</topic><topic>Male</topic><topic>Recurrence</topic><topic>Reed-Sternberg Cells - immunology</topic><topic>Rituximab</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karamouzis, Michalis V.</creatorcontrib><creatorcontrib>Apostolikas, Nikiforos</creatorcontrib><creatorcontrib>Georganta, Chara</creatorcontrib><creatorcontrib>Lainakis, Giorgos</creatorcontrib><creatorcontrib>Kandylis, Kostas</creatorcontrib><creatorcontrib>Rigatos, Gerasimos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karamouzis, Michalis V.</au><au>Apostolikas, Nikiforos</au><au>Georganta, Chara</au><au>Lainakis, Giorgos</au><au>Kandylis, Kostas</au><au>Rigatos, Gerasimos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case of relapsed CD20(+) mixed‐cellularity Hodgkin disease treated with sequential rituximab and radiotherapy</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2004-12</date><risdate>2004</risdate><volume>77</volume><issue>4</issue><spage>418</spage><epage>419</epage><pages>418-419</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15551291</pmid><doi>10.1002/ajh.20224</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0361-8609 |
| ispartof | American journal of hematology, 2004-12, Vol.77 (4), p.418-419 |
| issn | 0361-8609 1096-8652 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_19730656 |
| source | MEDLINE; Wiley Online Library; EZB-FREE-00999 freely available EZB journals |
| subjects | Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antigens, CD20 - immunology Antineoplastic Agents - therapeutic use Combined Modality Therapy Hodgkin Disease - drug therapy Hodgkin Disease - immunology Hodgkin Disease - pathology Hodgkin Disease - radiotherapy Humans Male Recurrence Reed-Sternberg Cells - immunology Rituximab Treatment Outcome |
| title | Case of relapsed CD20(+) mixed‐cellularity Hodgkin disease treated with sequential rituximab and radiotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A57%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20of%20relapsed%20CD20(+)%20mixed%E2%80%90cellularity%20Hodgkin%20disease%20treated%20with%20sequential%20rituximab%20and%20radiotherapy&rft.jtitle=American%20journal%20of%20hematology&rft.au=Karamouzis,%20Michalis%20V.&rft.date=2004-12&rft.volume=77&rft.issue=4&rft.spage=418&rft.epage=419&rft.pages=418-419&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.20224&rft_dat=%3Cproquest_cross%3E19730656%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19730656&rft_id=info:pmid/15551291&rfr_iscdi=true |